title: [A randomized, prospective study of the treatment of proliferative vitreoretinopathy with daunomycin].
authors.forename: P
authors.initials: P
authors.lastname: Wiedemann
authors.forename: K D
authors.initials: KD
authors.lastname: Lemmen
authors.forename: R
authors.initials: R
authors.lastname: Wiedemann
authors.forename: H
authors.initials: H
authors.lastname: Moter
authors.forename: K
authors.initials: K
authors.lastname: Heimann
mesh_terms: D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation; D012164:Retinal Diseases / Q000188:drug therapy* / Q000601:surgery; D012827:Silicone Oils; D014821:Vitrectomy / Q000379:methods*
chemical_list: D012827:Silicone Oils; D003630:Daunorubicin
vernacular_title: Eine randomisierte, prospektive Studie zur Behandlung der proliferativen Vitreoretinopathie mit Daunomycin.